Dr Lau Hiu Yeung

MD, PhD, FRCPath

Associate Consultant

Clinical Appointments

Associate Consultant Department of Pathology and Laboratory Medicine KK Women's and Children's Hospital

Profile

Dr Lau Hiu Yeung is an associate consultant pathologist in the Department of Pathology and Laboratory Medicine, KK Women’s and Children’s Hospital.

Education

FRCPath (Royal College of Pathologists, UK), 2023
MD, PhD (Duke-NUS Medical School, Singapore), 2018
BS (Johns Hopkins University, USA), 2009

Professional Appointments and Committee Memberships

Associate Consultant, Department of Pathology and Laboratory Medicine, KK Women’s and Children’s Hospital 2024 - Present

Awards

Research Interests

Publications and Research Trials

Lau HY, Lee VTW, Lim KH. “Ossified retroperitoneal schwannoma: A rare diagnosis for a retroperitoneal nodule.” Asian J Surg, 45(1): 613-615 (2022)
Ong CHC, Lee DY, Lee B, Li H, Lim JCT, Lim JX, Yeong JPS, Lau HY, Thike AA, Tan PH, Iqbal J. “Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer.” Breast Cancer Res. 24(1): 38 (2022)
Ho MY, Chen Y, Lee YT, Seng MSF, Lau HY, Teo CEH, Tay ZY, Loh AHP. “Thyroglossal duct cyst carcinoma in the pediatric population: a case report and literature review.” Front Med Case Rep. 3:5 (2022)
Lau HY, Tang J, Casey PJ, Wang M. “Evaluating the Epithelial-Mesenchymal Program in Human Breast Epithelial Cells Cultured in Soft Agar Using a Novel Macromolecule Extraction Protocol.” Cancers (Basel), 13(4): 807 (2021)
Lau HY, Wang M., “Small change, big effect: Taking RAS by the tail through suppression of post-prenylation carboxylmethylation.” Small GTPases,11(4): 271-279 (2020)
Lau HY, Tang J, Casey PJ, Wang M., “Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms.” Oncogene, 36(27): 3934-3942 (2017)
Lau HY, Ramanujulu PM, Guo D, Yang T, Wirawan M, Casey PJ, Go ML, Wang M., “An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo.” Cancer Biol Ther.,15(9): 1280-91 (2014)
Ghosh S., Lau H., Simons BW, Powell JD, Meyers DJ, De Marzo AM, Berman DM, Lotan TL. “PI3K/mTOR signaling regulates prostatic branching morphogenesis.” Developmental Biology, 360(2): 329-42 (2011)
McFarlane C., Gu ZH, Wong ZW, Lau HY, Lokireddy S., Ge X., Mouly V., Butler-Browne G., Gluckman PD., Sharma M., Kambadur R., “Human myostatin negatively regulates human myoblast growth and differentiation.” Am J. Physiol Cell Physiol., 301(1): C195-203 (2011)